BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Matsushita K, Shimada H, Ueda Y, Inoue M, Hasegawa M, Tomonaga T, Matsubara H, Nomura F. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy. World J Gastroenterol 2014; 20(15): 4316-4328 [PMID: 24764668 DOI: 10.3748/wjg.v20.i15.4316]
URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4316.htm
Number Citing Articles
1
Ekati Drakopoulou, Nicholas P. Anagnou, Kalliopi I. Pappa. Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success StoryCancers 2022; 14(13): 3238 doi: 10.3390/cancers14133238
2
N Tanaka, K Araki, D Mizokami, Y Miyagawa, T Yamashita, M Tomifuji, Y Ueda, M Inoue, K Matsushita, F Nomura, H Shimada, A Shiotani. Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancerGene Therapy 2015; 22(4): 297 doi: 10.1038/gt.2014.123
3
Daisuke Mizokami, Koji Araki, Nobuaki Tanaka, Hiroshi Suzuki, Masayuki Tomifuji, Taku Yamashita, Yasuji Ueda, Hideaki Shimada, Kazuyuki Matsushita, Akihiro Shiotani, Arun Rishi. Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal StenosisPLOS ONE 2015; 10(1): e0116279 doi: 10.1371/journal.pone.0116279
4
Bahityar Rahmutulla, Kazuyuki Matsushita, Fumio Nomura. Alternative splicing of DNA damage response genes and gastrointestinal cancersWorld Journal of Gastroenterology 2014; 20(46): 17305-17313 doi: 10.3748/wjg.v20.i46.17305
5
Kazuyuki Matsushita, Kouichi Kitamura, Bahityar Rahmutulla, Nobuko Tanaka, Takayuki Ishige, Mamoru Satoh, Tyuji Hoshino, Satoru Miyagi, Takeshi Mori, Sakae Itoga, Hideaki Shimada, Takeshi Tomonaga, Minoru Kito, Yaeko Nakajima-Takagi, Shuji Kubo, Chiaki Nakaseko, Masahiko Hatano, Takashi Miki, Masafumi Matsuo, Masaki Fukuyo, Atsushi Kaneda, Atsushi Iwama, Fumio Nomura. Haploinsufficiency of thec-myctranscriptional repressorFIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1Oncotarget 2015; 6(7): 5102 doi: 10.18632/oncotarget.3244
6
Caiqi Ma, Zhijian Huang, Zhikun Wu, Chunguang Di, Xueping Lin, Mao Huang, Honghai Hong, Haofan Yin. Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosisLife Sciences 2021; 269: 119098 doi: 10.1016/j.lfs.2021.119098
7
Assaf Magen, Avinash Das, Joo Sang Lee, Mahfuza Sharmin, Alexander Lugo, J. Silvio Gutkind, Alejandro A. Schäffer, Eytan Ruppin, Sridhar Hannenhalli. Beyond Synthetic Lethality: Charting the Landscape of Clinically Relevant Genetic Interactions in CancerSSRN Electronic Journal 2019;  doi: 10.2139/ssrn.3329251
8
M Kano, K Matsushita, B Rahmutulla, S Yamada, H Shimada, S Kubo, T Hiwasa, H Matsubara, F Nomura. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beamsGene Therapy 2016; 23(1): 50 doi: 10.1038/gt.2015.84
9
Assaf Magen, Avinash Das Sahu, Joo Sang Lee, Mahfuza Sharmin, Alexander Lugo, J. Silvio Gutkind, Alejandro A. Schäffer, Eytan Ruppin, Sridhar Hannenhalli. Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in CancerCell Reports 2019; 28(4): 938 doi: 10.1016/j.celrep.2019.06.067
10
Ángela Áyen, Yaiza Jiménez Martínez, Houria Boulaiz. Targeted Gene Delivery Therapies for Cervical CancerCancers 2020; 12(5): 1301 doi: 10.3390/cancers12051301